Therapeutic Effects of Eugenol in Polycystic Ovarian Rats Induced by Estradiol Valerate: A Histopathological and A Biochemical Study

Document Type : Original Article


1 Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

2 Department of Anatomy, Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran

3 A&S Research Institute, Ministry of Science Research and Technology, Tehran, Iran


Background: Polycystic ovary syndrome (PCOS) is a common type of endocrinopathy in women which is accompanied by androgens elevation, insulin resistance, and metabolic dysfunction. Eugenol is a phenolic component of clove oil that has an antioxidant, anti-inflammatory, and anti-diabetic activity. The present study aimed to evaluate the therapeutic effects of eugenol on the PCOS models of rats.
Materials and Methods: In this experimental study, thirty adults female Wistar rats weighing between 180 and 200 g were used. Estradiol valerate-induced PCOS rats (4 mg/rat) were treated with eugenol (12 and 24 mg/kg) for 28 days. The effects of eugenol were studied on levels of glucose, lipid profile, liver enzymes, reproductive hormones, oxidative stress, and the expression of cyclooxygenase-2 (Cox-2) and peroxisome proliferator-activated receptor alpha (Ppar-α) genes, using biochemical analysis of blood and histopathological evaluation of ovaries.
Results: Estradiol valerate-induced PCOS resulted in the formation of cystic follicles in the ovaries, hyperinsulinemia, hyperglycemia, hyperlipidemia, hyperandrogenism, and anovulation. It altered the Cox-2 and Ppar-α gene expression and increased oxidative stress and activities of liver enzymes. Eugenol treatment improved the PCOS-associated endocrine and metabolic disorder and histopathological alterations, mostly through antioxidant, anti-diabetic, anti hyperlipidemic, and anti-androgenic properties. It showed beneficial effects on serum glucose, serum insulin, fat profile, reproductive hormones, liver activity, oxidative stress, expression of Cox-2 and Ppar-α genes, as well as restoration of normal ovulation in the PCOS animals.
Conclusion: Eugenol could represent a promising natural product to prevent PCOS or reduce its symptoms.


  1. Lentscher JA, Slocum B, Torrealday S. Polycystic ovarian syndrome and fertility. Clin Obstet Gynecol. 2021; 64(1): 65-75.
  2. Garruti G, Depalo R, Vita M G, Lorusso F, Giampetruzzi F, Damato AB, et al. Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment. Reprod Biomed Online. 2009; 19 (4): 552-563.
  3. Duleba AJ, DokrasA. Is PCOS an inflammatory process? Fertil Steril. 2012; 97(1): 7-12.
  4. Hulsmans M, Holvoet P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med. 2010; 14(1-2): 70-78.
  5. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5): 270-284.
  6. Hasani-Ranjbar S, Larijani B. Medicinal plants as potential newtarget drugs in endocrine disorders-review article. Iran J Public Health. 2014; 43: 24-34.
  7. Dabaghian FH, Kamalinejad M, Shojaei A, Fard MA. Presenting anti-diabetic plants in Iranian traditional medicine. J Diabetes Endocrinol. 2012; 3(5): 70-76.
  8. de Araújo Lopes A, da Fonseca FN, Rocha TM, de Freitas LB, Araújo EV, Wong DV, et al., Eugenol as a promising molecule for the treatment of dermatitis: antioxidant and anti-inflammatory activities and its nanoformulation. Oxid Med Cell Longev. 2018; 2018: 8194849.
  9. Manikandan P, Vinothini G, Vidya Priyadarsini R, Prathiba D, Nagini S. Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG. Invest New Drugs. 2011; 29(1): 110-117.
  10. Callejas NA, Casado M, Bosca L, Martín-Sanz P. Requirement of nuclear factor kappa B for the constitutive expression of nitric oxide synthase-2 and cyclooxygenase- 2 in rat trophoblasts. J Cell Sci. 1999; 112(18): 3147-3155.
  11. Marnett LJ. Cyclooxygenase mechanisms. Curr Opin Chem Biol. 2000; 4: 545-552.
  12. Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem. 1998; 273(49): 32833-32841.
  13. Committee for the update of the guide for the care and use of laboratory animals. Guide for the care and use of laboratory animals. Washington: National Academy Press; 1996.
  14. Abtahi-Eivari SH, Moghimian M, Soltani M, Shoorei H, Asghari R, Hajizadeh h, et al. The effect of Galega officinalis on hormonal and metabolic profile in a rat model of polycystic ovary syndrome. Int J Women's Health Reprod Sci. 2018; 6(3): 276-282.
  15. Taghvaee Javanshir S, Yaghmaei P, Hajebrahimi Z. Thymoquinone ameliorates some endocrine parameters and histological alteration in a rat model of polycystic ovary syndrome. Int J Reprod Bio Med. 2018; 16 (4): 275-284.
  16. Williams CJ, Erickson GF. Morphology and physiology of the ovary.

In: Feingold KR, Anawalt B, Boyce A, Chrousos J, de Herder WW, Dhatariya K, et al., editors. Endotext. South Dartmouth (MA):, Inc.; 2000. Available from: https://www.ncbi.nlm.nih. gov/books/NBK278951/ (30 Jan 2012).

  1. Simard M, Brawer JR, Farookhi R. An intractable, ovaryindependent impairment in hypothalamo-pituitary function in the estradiol-valerate induced polycystic ovarian condition in the rat. Biol Reprod. 1987; 36(5): 1229-1237.
  2. Venegas B, Gordillo LY, Rosas G, Espinoza JA, Morán R, Domínguez C, et al. In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation. Reprod Biol Endocrin. 2019; 17 (95): 1-10.
  3. Khodaeifar F, Fazljou SMB, Khaki A, Torbati M, Olad Saheb Madarek E, Khaki AA, et al. The effect of hydroalchoholic extract of cinnamon zeylanicum on oxidative damages and biochemical change in adult rats with polycystic ovary syndrome. Crescent J Medical Biol Sci. 2019; 6 (4): 511-516.
  4. Oktay K, Newton H, Mullan J, Gosden RG. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Hum Reprod. 1998; 13(5): 1133- 1138.
  5. Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev. 2009; 30(6): 624-712.
  6. Tyndall V, Broyde M, Sharpe R, Welsh M, Drake AJ, McNeilly AS. Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats. Reproduction. 2012; 143(1): 21-33.
  7. Holmäng A, LarssonBM, Brzezinska Z, Björntorp P. Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats. Am J Physiol. 1992; 262(6): E851-E855.
  8. Ismail H, Scapozza L, Ruegg U, Dorchies O. Diapocynin, a dimer of NADPH oxidase inhibitor apocynin, reduces ROS production and prevents force loss in eccentrically contracting dystrophic muscle. PLoS Med. 2014; 9(10): e110708.
  9. Mohammadi M. Oxidative stress and polycystic ovary syndrome: a brief review. Int J Prev Med. 2019; 10: 86.
  10. Ho E, Karimi Galougahi K, Liu CC, Bhindi R, Figtree GA. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol. 2013; 1(1): 483-491.
  11. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab. 2007; 18(7): 280-285.
  12. Karateke A, Dokuyucu R, Dogan H, Ozgur T, Tas ZA, Tutuk O, et al. Investigation of therapeutic effects of erdosteine on polycystic ovary syndrome in a rat model. Med Princ Pract. 2018; 27(6): 515- 522.
  13. Alamri ZZ. The role of liver in metabolism: an updated review with physiological emphasis. Int J Basic Clin Pharmacol. 2018; 7(11): 2271-2276.
  14. Zhang Y, Meng F, Sun X, Sun X, Hu M, Cui P, et al. Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver. Oncotarget. 2018; 9(26): 18180-18197.
  15. Music M, Dervisevic A, Pepic E, Lepara O, Fajkic A, Ascic-Buturovic B, et al. Metabolic syndrome and serum liver enzymes level at patients with type 2 diabetes mellitus. Med Arch. 2015; 69(4): 251-255.
  16. Osman NN, Alsahfi SA, Alshubaily F. Effectiveness of aqueous extract of fenugreek seeds and flaxseed on polycystic ovarian syndrome in female rats. Int J Pharm Res Allied Sci. 2019; 8(4): 42-54.
  17. Sanchez-Valle V, Chavez-Tapia NC, Uribe M, Mendez-Sanchez N. Role of oxidative stress and molecular changes in liver fibrosis: A review. Curr Med Chem. 2012; 19(28): 4850-4860.
  18. Burri L, Thoresen GH, Berge RK. The role of PPARα activation in liver and muscle. PPAR Res. 2010; 2010: 542359.
  19. Karimzadeh L, Nabiuni M, Mohseni Kouchesfehani H, Adham H, Bagheri A, Sheikholeslami A. Effect of bee venom on IL-6, COX-2 and VEGF levels in polycystic ovarian syndrome induced in Wistar rats by estradiol valerate. J Venom Anim Toxins Incl Trop Dis. 2013; 19(1): 32.
  20. Wang YX, Zhu WJ, Xie BG. Expression of PPAR-γ in adipose tissue of rats with polycystic ovary syndrome induced by DHEA. Mol Med Rep. 2014; 9(3): 889-893.
  21. Moghimian M, Aalami S, Abtahi-Evari SH, Soltani M. Effect of Syzygium aromaticum (clove) extract on morphine withdrawal side effect in male reproductive system should be addressed. Physiol Pharmacol. 2018; 22(2): 109-117.
  22. Poli V, Challa C. A comparative study of eugenol and Ocimum sanctum Linn. leaf extract on the antifertility effect in female albino rats. J Chin Med Assoc. 2019; 82(3): 231-234.
  23. Barghi B, Shokoohi M, Khaki AA, Khaki A, Moghimian M, Soltani M. Eugenol improves tissue damage and oxidative stress in adult female rats after ovarian torsion/detorsion. J Obstet Gynaecol. 2021; 41(6): 933-938.
  24. Al-Trad B, Alkhateeb H, Alsmadi W, AlZoubi M. Eugenol ameliorates insulin resistance, oxidative stress and inflammation in high fat-diet/ streptozotocin-induced diabetic rat. Life Sci. 2019; 216: 183-188.